BioNTech SE
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $128,700 | $129,350 | $1,479,000 | $1,479,000 |
Gross Profit | 68,900 | 69,248 | 1,299,900 | 1,299,900 |
EBITDA | -652,885 | 507,400 | 507,400 | |
EBIT | -703,037 | 428,600 | 430,621 | |
Net Income | -807,800 | -811,885 | 457,900 | 457,900 |
Net Change In Cash | 128,700 | 129,350 | 1,479,000 | 1,479,000 |
Free Cash Flow | 1,485,900 | 1,500,662 | 660,700 | 660,700 |
Cash | 10,376,700 | 10,382,803 | 11,663,700 | 11,663,700 |
Basic Shares | 237,766 | 237,725 | 241,874 | 241,874 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,819,000 | $17,310,600 | $18,976,700 | $482,325 |
Gross Profit | 3,219,200 | 12,778,600 | 15,116,000 | -222,037 |
EBITDA | 1,155,400 | 13,096,300 | 14,970,700 | -42,109 |
EBIT | 975,759 | 12,975,220 | 14,892,500 | -78,206 |
Net Income | 930,300 | 9,434,400 | 10,292,500 | 15,200 |
Net Change In Cash | 3,819,000 | 17,310,600 | 18,976,700 | 482,325 |
Free Cash Flow | 4,665,900 | 13,214,100 | 735,700 | -98,920 |
Cash | 11,663,700 | 13,875,100 | 1,692,700 | 1,210,209 |
Basic Shares | 242,700 | 249,800 | 259,700 | 248,527 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$3.36 |
2024-03-31 | -$1.41 |
2023-12-31 | $1.90 |
2023-09-30 | $0.67 |
